Herpes zoster and postherpetic neuralgia

Robert W Johnson

doi:10.1586/erv.10.30

journal article Mar 01, 2010

Herpes zoster and postherpetic neuralgia

Robert W Johnson

Expert Review of Vaccines Vol. 9 No. sup3 pp. 21-26 · Informa UK Limited

View at Publisher Save 10.1586/erv.10.30

Topics

No keywords indexed for this article. Browse by subject →

References

39

[1]

Kost N. Engl. J. Med. (1996) 10.1056/nejm199607043350107

[2]

Kimberlin N. Engl. J. Med. (2007) 10.1056/nejmct066061

[3]

Arvin N. Engl. J. Med. (2005) 10.1056/nejmp058091

[4]

Bowsher Eur. J. Pain (1999) 10.1016/s1090-3801(99)90015-0

[5]

Donahue Arch. Intern. Med. (1995) 10.1001/archinte.1995.00430150071008

[6]

Johnson Expert Rev. Neurotherapeutics (2007) 10.1586/14737175.7.11.1581

[7]

de Melker Vaccine (2006) 10.1016/j.vaccine.2006.02.017

[8]

Kilgore J. Med. Virol. (2003) 10.1002/jmv.10364

[9]

Hope-Simpson Proc. R. Soc. Med. (1965)

[10]

Paul Hautarzt (1996) 10.1007/s001050050476

[11]

di Luzio Paparatti J. Infect. (1999) 10.1016/s0163-4453(99)90079-8

[12]

Chidiac Clin. Infect. Dis. (2001) 10.1086/320884

[13]

Brisson J. Med. Virol. (2003) 10.1002/jmv.10313

[14]

Gauthier Epidemiol. Infect. (2008)

[15]

Schmader Clin. Infect. Dis. (2001) 10.1086/320169

[16]

Miller Rev. Med. Microbiol. (1993) 10.1097/00013542-199310000-00006

[17]

Dworkin Clin. Infect. Dis. (2007) 10.1086/510206

[18]

Johnson Drugs Aging (2008) 10.2165/0002512-200825120-00002

[19]

Oxman N. Engl. J. Med. (2005) 10.1056/nejmoa051016

[20]

Scott Vaccine (2006) 10.1016/j.vaccine.2005.09.026

[21]

Schmader J. Infect. Dis. (1995) 10.1093/infdis/171.3.701

[22]

Schmader J. Am. Geriatr. Soc. (1998) 10.1111/j.1532-5415.1998.tb02751.x

[23]

Schmader Clin. J. Pain (2002) 10.1097/00002508-200211000-00002

[24]

Schmader Clin. J. Pain (2007) 10.1097/ajp.0b013e318065b6c9

[25]

Johnson Aging Clin. Exp. Res. (2009) 10.1007/bf03324909

[26]

Li Q, Chen N, Yang Jet al.Antiviral treatment for preventing postherpetic neuralgia. The Cochrane Collaboration 2, 1–43 (2009). 10.1002/14651858.cd006866.pub2

[27]

Wood N. Engl. J. Med. (1994) 10.1056/nejm199403313301304

[28]

Whitley Antiviral Res. (1995) 10.1016/0166-3542(95)94843-q

[29]

van Wijck Lancet (2006) 10.1016/s0140-6736(06)68032-x

[30]

Paek Gerontology (2009)

[31]

Oaklander J. Pain (2003) 10.1016/s1526-5900(03)00637-0

[32]

Hempenstall PLoS Med. (2005) 10.1371/journal.pmed.0020164

[33]

Wu J. Pain (2008) 10.1016/j.jpain.2007.10.006

[34]

Finnerup Pain (2005) 10.1016/j.pain.2005.08.013

[35]

Dubinsky Neurology (2004) 10.1212/01.wnl.0000140708.62856.72

[36]

Kotani N. Engl. J. Med. (2000) 10.1056/nejm200011233432102

[37]

Gilron Nat. Clin. Pract. Neurol. (2008) 10.1038/ncpneuro0836

[38]

Gilron N. Engl. J. Med. (2005) 10.1056/nejmoa042580

[39]

Gilron Lancet (2009) 10.1016/s0140-6736(09)61081-3

Metrics

116

Citations

39

References

Details

Published: Mar 01, 2010
Vol/Issue: 9(sup3)
Pages: 21-26

Authors

R

Robert W Johnson

Cite This Article

Robert W Johnson (2010). Herpes zoster and postherpetic neuralgia. Expert Review of Vaccines, 9(sup3), 21-26. https://doi.org/10.1586/erv.10.30

Herpes zoster and postherpetic neuralgia

You May Also Like